StockData
Arcturus Therapeutics Holdings Inc. logo

Arcturus Therapeutics Holdings Inc. (ARCT) stock

ARCTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3010% below fair value
$8.04+0.07 (+0.88%)

Close on Nov 18, 2026Market cap $228.52MP/E –Yield –

Arcturus Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Arcturus Therapeutics's pe ratio was 8.9× on Jan 31, 2024.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 20248.9×+0.4
2023Dec 29, 20238.5×–

More Arcturus Therapeutics figures

See a number that looks wrong?